Early diagnosis of Amyotrophic Lateral Sclerosis (ALS) and other neurodegenerative disorders

Patent number:

EP22383245

Comunidad de Madrid.svg
No items found.

An in vitro fluorescent method for early detection of Amyotrophic Lateral Sclerosis (ALS) and other TDP-43 related proteinopathies, such as Fronto Temporal Lobar Degeneration (FTLD), based on detection of pathological aggregates of TDP-43 present in cerebrospinal fluid

Countries:
Spain
Regions:
Community of Madrid
Centers:
CSIC
Other entities:
Sectors:
Health
Subsectors:
TRL Level:
TRL 3 – experimental proof of concept
BRL Level:
PDF Link:
Download here
Video Link:
Watch it here
Sustainable Development Goal:
Applications

Los polipéptidos de TDP-43 oxidados desarrollados son fáciles de producir y exhiben mayor homogeneidad, estabilidad y selectividad que los péptidos de TDP-43 no modificados. Aplicación para la detección de la ELA y otros trastornos neurodegenerativos, como la DLFT, ELA-DLFT, la enfermedad de Alzheimer o la enfermedad de Parkinson. Método útil para el cribado de compuestos útiles para tratar o prevenir las proteinopatías por TDP-43.

Comments

Other related patents

Health

NEW PHARMACOLOGICAL STRATEGY AGAINST RESISTANT DEPRESSION

Countries
Spain
Know more
Chemicals
Health

Phenylpropanoid saccharide esters, methods and uses thereof

Countries
Portugal
Know more
Health

CRHR1 agonists: an innovative approach for the treatment of the social anxiety disorder.

Countries
Spain
Know more
Get back to patents directory